FDA WARNING_LETTER - Vapor Candy Inc d/b/a The Vape Stop - December 01, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
On December 1, 2022, the FDA issued a Warning Letter to Vapor Candy Inc d/b/a The Vape Stop, following a review of submissions and inspection records. The FDA determined that the company manufactures and distributes e-liquid products, which are classified as tobacco products under section 201(rr) of the FD&C Act, as amended by the Consolidated Appropriations Act, 2022, to include nicotine from any source.
The primary violation identified is the marketing of a "new tobacco product," specifically Vapor Candy Xtra Sweet VS Reserve 6MG e-liquid, without the required premarket authorization. This product was not commercially marketed in the U.S. as of February 15, 2007, and lacks an FDA marketing authorization order, a substantial equivalence order, or an exemption. Consequently, the product is deemed adulterated under section 902(6)(A) and misbranded under section 903(a)(6) of the FD&C Act due to the failure to provide required notice or information under section 905(j).
These actions constitute prohibited acts under sections 301(k) and 301(p) of the FD&C Act. The FDA requires the company to submit a written response within 15 working days, detailing actions taken to address the violations, including discontinuing the sale and distribution of the non-compliant
ID · f6780d82-d8a4-4657-b229-ba7c6e08fee1
Full citation text and observation details available on the Dashboard.